Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...